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Summary.-In a study of 157 patients with lymphoid malignancy, the phenotype
of the tumour cells was correlated with the histological classification of the tumour
using the Rappaport and the Kiel classifications. The markers used included E, Fcy,
Fc,u(IgM) and C3drosetting, estimation of SIg and CyIg, and tests for the expression
of HTLA, Ia and ALL. Repeat biopsy specimens were studied in 23 of these patients.
The phenotypic features of lymphoblastic malignancy indicated B-cell, T-cell and
ALL-positive null-cell tumours in this group. Immunoblastic lymphomas were
predominantly of non-capping B-cell type, but T-cell immunoblastic lymphoma
occurred in 2 patients. Immunoblastic lymphomas of receptor-silent cells occur,
and are ALL- and HTLA-negative. In the category of diffuse, poorly differentiated
lymphocytic lymphomas, most cases are of centroblastic and centrocytic tumour of
diffuse type, but pure centrocytic tumours and centroblastic tumours occur. The
dominant phenotype in this group is of B cells expressing C3d receptors. Nodular
poorly differentiated lymphocytic lymphomas (Rappaport) are classified as centro-
blastic and centrocytic follicular (Kiel) and most express SIg+ C3d+ phenotype. The
frequency of this phenotype appeared the same in both diffuse and nodular poorly
differentiated lymphocytic neoplasms. The Rappaport group of diffuse well-differen-
tiated lymphocytic lymphoma includes 2 Kiel categories, malignant lymphoma
lymphocytic, and malignant lymphoma lymphoplasmacytoid. Cells of the former
tumour are considered to be immature B cells resembling those seen in CLL, and
characteristically expressing SIg weakly, with ahighfrequency ofsingle x light chain.
Cells of the latter tumour are by contrast mature, and are related to the centroblastic
and centrocytic follicular tumour by their histogenesis and phenotypic features.
Repeat biopsy examinations indicate that T-cell predominance occurs in the pro-
dromal phase of B-cell-predominant tumours of SIg+ C3d+ phenotype. It is concluded
that non-Hodgkin lymphoma can be divided into 2 categories: (1) tumours of imma-
ture immunologically incompetent cells of lymphoblastic histology and with pheno-
typic features akin to T, B and Null-cell ALL, and (2) tumours of differentiated lym-
phocytes expressing the phenotypic features of B lymphocytes, with maturation
arrested at one of several stages of an antigen-dependent immune response.
IT HAS BEEN SUGGESTED that the cells & Seligmann, 1974; Stuart & Habeshaw,
of malignant lymphomas are arrested at 1976; Habeshaw et al., 1977). The pheno-
different stages in their otherwise normal type of lymphoma cells may conversely
differentiation and maturation, and there- represent an abnormal phenotype result-
fore express the surface phenotype of ing from neoplastic transformation (Selig-
normal lymphoid cells of equivalent mann, 1974) as in cases ofT-celllymphoma
maturity (Lukes & Collins, 1974; Salmon expressing B-cell markers (Habeshaw &
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Stuart, 1975). More recently such tumours
have been shown to express the phenotype
of foetal thymic precursor cells (Stein et
al., 1976). Similarly, expression of the
surface antigen associated with acute
lymphoblastic leukaemia cells (ALL anti-
gen; Roberts et al., 1978) and the
enzyme terminal deoxynucleotidyl trans-
ferase (TdT; MeCaffrey et al., 1975;
Donlon etal., 1977; Kung et al., 1978) have
both been shown to be markers of cellular
immaturity rather than of malignancy.
These observations strongly suggest that
the surface phenotype of non-Hodgkin
TABLE 1.-Published data relatiny phenotypic expression to lymphoid differentiation in
non-Hodgkin lynmphorna, leitkaemia and normal subjects
Profile
ALL+, Ia, TdT+
ALL+, la,, T(IT
Cy1gMNP+
HTLA+, TdIT+, E-
E+, HTLA+, TdT
E+,C3+, TdT+
E,+ igM tFFc C3+(1a+)
SIg+ (Weak explression)
SIg'-Fc+1gAIM-
Sig+Fc+TgM+C3+
SIg+Fc+C3t
Sig+C3:
SIg- (capping)
Stg (non-capp)inig)
S lg CyIg+
CyIg
Class of malignancy
ALL/ML LB/DUT
ALL
Normal equivalent
Lymphoid stem cell
Pre-B cell
ALL/ML LB/DIT Pr-ethymic T cell
ALL/MIL LB(T)/DlJ Thymic T cell
Steiniberg saIcoma/ALL T precursor
ML LB(T)/DIJ
Cells associatedl wxith
CLL, ALL, HD,
lymphoma
CLL/MILL/DWDL
CLL/MLL/DWDL
CLL/IMLL/DWDL
? CLL/1\MLL/DWDL
(B/cc/F or D
N or DPDL
NPDL, DPDL, cc/Sc,
CB/cc/F
MIL IB/DHL
ML IB/DH
"Burkitt"/DIJ
Plasmacytoma
FuTnctional T cell
Slubsets
Immatture B cell
Immature B cell
V Virgin B cell
? Memory B cell/
mantle zone
lymphocyte
Geriminal follicle
centre cell
Medullary cor(d
lymphocyte (pro-
plasma cell)
"Plasmablast"
pro-plasma cell
Pro-plasma cell
Plasma cell
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lymphoma cells identifies cells which have
undergone maturation arrest at various
critical points in their normal differentia-
tion and maturation sequence. The pheno-
types of malignant lymphoma cells and
their relationships to normal lymphoid
cells of equivalent phenotype are shown
in Table I and discussed in the references
given.
The purpose of this study was three-
fold. Firstly, a panel of membrane and
cytoplasmic markers was developed and
standardized. The expression of surface
immunoglobulin (SIg), the redistribution
of SIg molecules on the cell surface, the
expression of C3d, Fcy and FcH receptors
and ofcytoplasmic immunoglobulin (CyIg)
are all probably related to the different
stages of B-cell maturation and function,
and their inclusion in a "receptor profile"
of lymphoma is important. Secondly, the
dominant cell populations in various
normal and reactive lymphoid tissues
were analysed with these markers. Thirdly,
the characteristics of neoplastic popula-
tions from 157 cases of non-Hodgkin
lymphoma were established, and corre-
lated with the histopathological and cyto-
logical features of these tumours. The
sequential analysis of serial samples from
some of these patients suggested certain
developmental links between the different
subclasses of lymphoma and their normal
equivalent B-cell subtypes.
MATERIALS AND METHODS
Tissues from 157 patients with non-
Hodgkin lymphoma were studied. These in-
cluded 44 patients with CLL whose blood was
studied. Single-cell suspensions were pre-
pared from various lymphoid organs. Blood,
marrow and spleen suspensions were separ-
ated on Ficoll-Triosil, and surface marking
performed on the recovered white-cell layers.
Touch preparations were made from the cut
lymph node surface and cytocentrifuge prep-
arations from cell suspensions. These were
studied by cytology and cytochemistry.
Trephine biopsy samples of marrow and
paraffin-embedded preparations were studied
by histology. Histological and cytological
diagnoses were made independently of know-
ledge of the receptor profile. The determina-
tion of the receptor profile of single-cell sus-
pensions was carried out as follows.
Preparation ofrosettes
E rosettes.-106 washed leucocytes were
mixed with 40 x 106 washed sheep RBC in
500 dul of Medium 199, incubated for 10 min
at 37°C, centrifuged for 5 min at 100 g, and
incubated in the pellet for 2 h at 4C. After
gentle resuspension, 5 pkl of 041% solution of
acridine orange was added, and the prepara-
tion examined wet using a microscope with
a tungsten-halogen light source and dichroic
filtered (narrow-band blue/red) light. The
stained nuclei fluoresce green, enabling the
easy identification of rosetting cells. Nucle-
ated intact cells binding more than 3 red cells
were counted as rosettes.
Fc rosettes.-Rabbit anti-ox-RBC IgG was
prepared from hyperimmune rabbit serum by
(NH4)2SO4 precipitation and DEAE-cellulose
chromatography. Optimal titre for red-cell
sensitization was determined as that titre
giving the maximum level of Fc rosetting by
normal blood mononuclear cells without
agglutination. Thenumbers ofrosettesformed
with increasing amounts of antibody on the
red cells shows a plateau at 20-35% rosettes
with samples of normal blood mononuclear
cells.
IgM rosettes.-Rabbit anti-ox-RBC IgM
was prepared by the i.v. injection of rabbits
with 2-5 mg/ml (wet wt) of ox erythrocyte
stroma suspended in 5% gelatin solution
(Kabat & Mayer, 1961). The first peak on
G-200 Sephadex chromatography (1gM) was
separated. IgM titres for red cell sensitization
(IgM rosettes) were selected by titration of
antibody dose against percentage rosettes
using IgM+ CLL cells. Kinetics of IgM
rosetting were similar to Fc rosetting, al-
though IgM rosettes are not formed in the
presence of free human IgM. Red cells
sensitized for 30 min at 37WC were used to
prepare rosettes by the same method as for
E rosettes.
C3d rosettes.-Ox RBC were coated with a
titre of rabbit-anti-ox-RBC IgM antibody
found to give optimal complement binding.
Sensitized cells were then treated with
human R3 reagent (Lachmann et al., 1973)
and washed twice. The receptor expressed is
the C3d receptor, since such cells react with
anti-human C3 antisera but are immune-
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adherence-negative. Rosetting was performed
as for E rosettes.
Quantitation ofphagocytes
Phagocytes wNere quantitated by mixing
106 WBC in 500 ,ul Medium 199 with 10 ,ul of
a, 1% aqueous solution of Neutral Red dye
(Gurr). After 15min incubation at 37WC the
cells were washed once in Medium 199, re-
suspended in 10 1l and counted. Macro-
phages show coarse clumped granular uptake
ofthe dye, myeloid cells a fine stippled uptake,
and lymphoblasts single discrete granules.
Dead cells show red nuclear staining.
Surface immunoglobulin staining and acetate
wa,shing
Non-specific binding of immune complexes
or immunoglobulin to the cell surface in vitro
or in vivo can lead to misinterpretation of
SIg patterns detected by immunofluorescence.
Following reports that Sig expression could
be enhanced by washing in acetate buffer at
low pH (Hutteroth et al., 1972) the folloNing
technique has been found useful in determin-
ing SIg expression by lymphoma cells.
Acetate buffer, at pH 5.5 containing 8-5 g/l
NaCl and 1.0 g/l CaCl2 was prepared. 10 ml
of buffer Awas added to 10-20 x 106 cells and
the suspension incubated for 10-15 min at
37°C. The cells wvere then washed once in
buffer and once in Medium 199, and incu-
bated for 1 h at 37°C. This procedure readily
displaces non-specifically bound Ig from CLL
B cells, and lymphoma B and T cells, wvithout
affecting expression of membrane-associated
(synthesized) 1g.
Surface Ig staining
Slg staining wvas performed on acetate-
buffer-washed cells. 106 cells wvere incubated
with FITC-conjugated antisera against y, 1,u
01, K and A chains for 30 min at 4°C,. washed
twice, and SIg+ cells counted using a Zeiss
photomicroscope 111 with incident UV
illumination and transmitted light for phase
contrast. Commercial antisera (Meloy, Bur-
roughs Wellcome, Dako, Behringwerke) were
used after appropriate titration and speci-
ficity tests. All antisera were deaggregated by
centrifugation at 110,000 g for 1 h before use.
Distribution ofSlg, capping (and non-capping
cells
Direct staining for SIg allows ob)servation
of the movement of the SIg-anti-Ig complex
on the cell surface. To demonstrate the
variable kinetics of the capping reaction in
B cells of different subclass, a sandwich tech-
nique was used. In this 106 cells were stained
with polyvalent rabbit anti-human y, ,t, a
heavy-chain antiserum at 4C for 30 min.
After being washed twice in ice-cold PBS, the
cells were stained with FITC-coupled goat
anti-rabbit serum (Meloy) or sheep anti-
rabbit serum (Burroughs Welleome) for 30
min at 4°C. After further washing in cold
PBS, the cells were warmed at 37WC for 15-20
min to allow capping to occur, and examined
immediately. This technique produces rapid
and consistent capping by nearly all normal
B cells. In some lymphomas the SIg remains
localized as small dots or patches on the
membrane (iion-capping) or the cells show
"slow capping" after 1-4 h incubation. In
cases (e.g. CLL) where Slg staining is weak,
it was not always possible to assess capping.
Cytoplasmnic Ig staining
Cytocentrifuge preparations were fixed in
cold absolute ethanol, brought to PBS, and
stained with 100 ,ul of the appropriate dilu-
tions of FITC-coupled antisera against y, ,u,
(, 8, K and A chains of immunoglobulin. After
2h washing in PBS, preparations were
mounted in Uvinert Aqueous (Gurr) and
examined for intracytoplasmic fluorescence.
Special staining
Where no E, Fc, C3, IgM or SIg was
detected on the cells, they were examined
with anti-ALL, anti-Ia and anti-HTLA sera
kindly provided by Drs M. Greaves, M.
Roberts and G. Janossy (ICRF Laboratories).
Classification of lymphomas by receptor profile
The proportions of different cell types in
the lesion were determined. T cells were
defined by E rosetting or HTLA positivity,
B cells by the presence of acetate-wash-
resistant Slg. Macrophages were defined by
Neutral Red ingestion and expression of Fe
receptor, and plasma cells had CyIg. Certain
cells lacked all markers (receptor-silent cells).
The samples were classified according to the
major cell type present.
T-cell-predominant tumours.-These could
be divided into those which have (a) <10%
of other cell types, (b) >10% of polyclonal
B cells ("T-predominant polyclonal B") and157 NON-HODGKIN LYMPHOMAS
(c) >10% of monoclonal B cells ("T-pre-
dominant monoclonal B"). In the T-cell-
predominant group (a), expression of Fc, C3
or IgM receptors was accounted positive if
expressed on more than 25%,' of the cells.
B-cell-predominant tumours.-These were
classified by the type of SJg expressed, and
by the subsidiary cell markers Fc, IgM and
C3. In most cases Fc and C3 receptors were
clearly expressed on the majority (B-cell)
population. In samples containing substantial
numbers of T cells it was not certain that Fc
and C3 receptor expression was limited to the
B-cell fraction. In a few cases, expression of
Fc and/or C3 receptor by the B cell was con-
firmed by the analysis of T-cell-depleted
populations. This was achieved by the
elimination of E rosetting cells on Ficoll-
Triosil. Fc, C3, IgM receptors were counted as
positive if expressed by more than 25% of
viable cells in the sample.
In B-cell-predominant lymphomas and
CLL the following B-cell profiles were
obtained:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
Capping SIg+
Non-capping SIg+
Weak SIg+
SIg+Fc+IgM+
SIg+Fc+
SIg+Fc+IgM+C3+
SIg+Fc+C3+
SIg+(Non-capping)C3+
SIg+C3+
SIg+CyIg+
SIg-CyIg+
Surface immunoglobulin
The expression of K and A light chains was
used to assess the monoclonality of SIg.
K-Chain monoclonality was arbitrarily defined
as a K/A chain ratio of 10 or greater. A-Chain
monoclonality was defined as a A/K chain
ratio of 5 or greater. Where 2 heavy chains
were expressed on the majority of SIg+ cells
in a monoclonal tumour, the lesion was
classified under both heavy-chain classes.
RESULTS-I
Normal tissues
Classiftcation ofnormal tissues by surface
marking.-Amongst the 37 normal and
reactive lymph nodes studied T cells were
the predominant population in 12 nodes,
2
T cells and B cells were present in roughly
equal proportions in 22 nodes and B cells
were predominant in 3 nodes. Nodes con-
tained mixtures of B cells of different
phenotype. The B-cell population in
normal or reactive nodes expressed C3
receptors only (13 cases), C3 and Fc re-
ceptors (5 cases) or SJg only (19 cases).
Numbers ofCylg+ cells were variable, but
generally <10%. In 24 tonsil samples, B
cells were the predominant population in
18 cases, and B and T cells present in equal
numbers in 6 cases. Plasma cells formed
2-11% of the tonsil cell population.
Almost all B cells in tonsil expressed C3d
receptors only. After elimination of T
cells, 5-23% of tonsil cells were SJg-
receptor-silent "null cells". Some of these
cells expressed Ia antigen, but were
HTLA- and Cylg-. In the 10 spleen
samples studied, T cells were the pre-
dominant population in 4, and T and B
cells present in equal proportion in 6.
Spleen B cells most commonly expressed
both Fc and C3 receptors, 10-24% of the
spleen cells were receptor-silent and
3-15% were identified as mononuclear
phagocytes. In all these samples, the B
cells seen expressed either K or A light
chains, and monoclonal B-cell populations
were never seen.
RESULTS-II
Peripheral blood in CLL (Table II)
In all but 2 of the 44 cases examined,
monoclonal SIg could be detected after
acetate washing and incubation of the
cells. In 2 cases, removal of polyclonal
SIg was followed by failure to detect any
SIg on the cells. In all samples studied, T
cells formed less than 10% of the circu-
lating population. SIg expression was in-
variably weak, and single-chain only (most
commonly ,u or K) in 26 cases. The surface
phenotype of the cases of CLL seen is
given in Table II. The most consistent
feature was the high incidence of IgM
receptor expression by CLL B cells in
peripheral blood (16/44). CLL B cells
expressing C3d receptor only were seen in
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TABLE II.-Surface phenotype in 44 cases
of chronic lymphocytic leukaemia (CLL)
Profile
SIg+Fc-C3-IgM-
Slg+Fc+C3-IgM+
Slg+Fc+C3+IgM+
SIg+Fc+C3+IgM-
SIg+Fc-C3+IgM-
SIg-Fe-C3-IgM-
No. of
cases
16
4
12
4
6
2
Key: Slg+=All B cells exhibit monoclonal SJg
resistant to acetate washing. Fc+, C3+, IgM+=Ex-
pression of receptor on more than 25% of B cells.
6/44 cases. Of the cases expressing light-
chain determinants (35/44), far more
expressed K (29) than A (6).
RESULTS-III
Surface phenotype in diffuse undifferen-
tiated lymphoma (DU)
The phenotype of 18 biopsy specimens
from 16 patients with DU are shown in
Table III. In 6 patients the phenotype
corresponded to that ofT-cell malignancy.
One patient (Bre.) had the phenotype of
E+ and C3d+ T cells. In 2 patients (Leg.,
Mad.(2)) the cells expressed HTLA, but
were E-. In 5 patients (Par., Hub., Edm.,
Bre., Hug.) the cells showed the cyto-
logical features of T lymphoblasts (con-
voluted nuclei, acid-phosphatase-positive).
The cells of patients Mad. and Leg. did
not show these features. Patients Par.,
Edm., Hug. were leukaemic at the first
biopsy (WBC>5±109/1) and showed X-
ray evidence of a mediastinal mass. In
Par. the lesion progressed to involve the
CSF, and the CSF cells werepredominantly
of T-cell type. In Patient Mad. the initial
diagnosis (histology and cytology) was
that ofhigh-grade pleomorphic lymphoma,
and the phenotype was of E+ cells. The
second biopsy showed lymphoblastic
lymphoma withoutthe characteristic cyto-
logical features ofT lymphoblasts, and the
cells were E- but HTLA+.
Four patients (Fel., Guy., Shep., Mas.)
had lesions composed of undifferentiated
lymphoblasts, and all were leukaemic on
biopsy. In 3 cases the cells were ALL+ and
Ia+, and in the 4th case insufficient cells
were obtained for testing. The lesions in
these patients correspond to ALL with
nodal involvement. Five patients (Ber.,
Fay., Bry., Bal., Gre.) had B-cell neo-
plasms. In 3 cases (Fay., Bal., Gre.) the
lymphoblasts showed Burkitt-lymphoma-
like features, allowing a cytological diag-
nosis of B lymphoblastic lymphoma. In 4
patients (Ber., Tay., Bry., Bal.) the
malignant cells failed to cap their SIg.
Patient Fay. was leukaemic at diagnosis,
and it is of interest that the marrow
lymphoblasts, but not the blood lympho-
blasts, showed the presence of CyIgM.
Patient Gre. presented with an ulcerating
scalp tumour in which a minority of the
lymphoblasts expressed CylgM.
Surface phenotype in diffuse histiocytic
lymphoma (DH) (Table IV)
Of the 17 cases of DH in this series, 12
had lesions containing a monoclonal B-
cell component. In 6 cases the B cells
failed to cap SIg, and in 3 patients capping
B cells were the major population. One
patient (God.) had polyclonal capping B
cells as the major component of his
tumour. Two patients (Smi., Mor.) had
lesions showing T-cell predominance asso-
ciated with monoclonal B cells, and one
patient (Lee.) had CyIg-containing B
cells as the major component of the
lesion. Patients Smi. (1, 2), Kos. (3), Has.
(2) and Lov. (1, 2, 3) had repeat biopsies.
Two patients had T-cell-predominant
tumours (Ham., Lov.). Lov. had a T-cell-
predominant tumour which became E- in
a subsequent biopsy (not tested with anti-
HTLA). Ham. had an immunoblastic
lymphoma of T-cell type. One patient
(Tun.) had a true receptor-silent tumour
(E- SIg- ALL- HTLA-). Two patients
(Byi., Fin.) were judged to have malignant
histiocytosis on cytology and cytochemis-
try. In both biopsy specimens large num-
bers of functional phagocytes were pres-
ent. In Patient Fin. these cells were
accompanied by a B-cell population ex-
pressing K chain only. Large receptor-17 157 NON-HODGKIN LYMPHOMAS
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silent cell populations were also present in
these cases.
Comparing the Kiel classification with
the surface markers in this group, the
diagnosis of "immunoblastic malignant
lymphoma" (ML IB) corresponded closely
with B-cell predominant tumours, the
exception being patient Tun. who had a
receptor-silent neoplasm. In 2 patients,
Smi. (2), Hug., the diagnosis indicated
immunoblastic transformation in a centro-
blastic and centrocytic tumour. Both T-
cell-predominant monoclonal B - cell
tumours were diagnosed as "malignant
lymphoma centroblastic" in the Kiel
classification. The cases of T-cell malig-
nancy were classified as a "centrocytic
tumour oflarge cell type", and as ML IB.
The evidence from this series shows that
the majority of DH lymphomas are of
B-cell derivation, and are composed of
large cells which are slow to cap SIg anti-
immunoglobulin complex. T-cell lymph-
omas are rare in this histological class.
DH lymphomas which lack surface Ig,
Fc, C3d and E receptors may contain
CyIg, or may be receptor silent. True
histiocytic malignancies are rare.
Surface phenotype in diffuse poorly differ-
entiated lymphocytic lymphoma (DPDL)
(Table V)
Twenty-four patients in this group con-
tributed 27 biopsy specimens of involved
tissue. In all but 4 patients the lesion
examined was B-cell predominant. In the
remaining 4 biopsy specimens, 2 showed
T-cell predominance with monoclonal B
cells, and 2 T-cell predominance with
polyclonal B cells. No receptor-silent
tumours occurred in this group. Four
patients had non-capping B-cell tumours,
all classified as centrocytic tumours of
large or pleomorphic cell type (Kiel).
Three patients had non-capping tumours
expressing C3d receptor, all classified as
centrocytic tumours of small cell type
(Kiel). Nine patients had capping tumours
expressing C3d receptors, and one ofthese
(Mat.) showed monoclonal IgG in the
cytoplasm of 10% of the tumour cells.
Six biopsy specimens showed a B-cell-
predominant pattern with the phenotype
SJg+, and 2 of these were polyclonal. Five
patients had low-grade tumours which
could not be definitively assigned to any
single class in the Kiel classification,
although the phenotype in two of these
cases (Wil., Mat.) was that ofthe follicular
tumour (SIg+ C3d+: Kiel equivalent
centroblastic/centrocytic/diffuse).
Surface phenotype in nodular poorly differ-
entiated lymphocytic lymphoma (NPDL)
(Table VI)
Thirty-two patients in this class pro-
vided 47 profiles. The majority ofpatients
(27/32) presented with tumours in which
B cells were the predominant population,
or with T-cell-predominant tumours con-
taining monoclonal B cells. Non-capping
B-cell tumours presented in 5 patients.
In Gig. (3) the tumour cells capped
slowly, rather than failing to cap at all. In
12 patients, the first lesion in the series
showed a predominant population of B
cells with S1g+C3d+ phenotype. This was
the most frequent profile in tumours of
this class. Seven patients had lesions in
which capping SIg+ cells were the major
population. Four patients had T-cell-
predominant lesions on presentation, and
these patients all eventually showed
B-cell monoclonality, in contrast to some
of the T-cell-predominant tumours of
DPDL, DH, or DU classes. No true
nodular T-cell tumour has been seen in
this series. Two tumours (Ayl. (1), Tay)
showed the unusual profile of SIg+Fc+C3+
B-cell predominance, and 2 tumours were
receptor-silent (Eve., Spe.). Only one of
the nodular tumours (Ted. (3a)) showed
CyIg in more than 10% of cells. Corre-
lating phenotype with histological classi-
fication, most of the lesions expressing
only surface immunoglobulin (SIg+ cap-
ping) showed sclerosis of the node on
histological examination. All the lesions
classified as "nodular poorly differenti-
ated", or as "nodular mixed", were classi-
fied as "centroblastic centrocytic follicu-157 NON-HODGKIN LYMPHOMAS 21
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lar" in the Kiel classification. The same
proportion of SIg+C3+ profiles (43O%)
were found in NPDL as in DPDL (40%)
in this series, a finding at variance with
those in some ofthe published work show-
ing a higher proportion ofnodular lymph-
omas with this profile.
Surface markers in diffuse well differ-
entiated malignant lymphoma (DIVDL)
(Table VII)
DWDL was diagnosed in 17 patients
contributing 19 profiles. In the cases of
Tuc. (1, 2, 3), Bas., Smi., New., these
lesions were associated with lymphocyte
counts >5 x 109/1. Most cases exhibited
weak SIg staining after acetate washing, a
feature constantly associatedwithtumours
of this class, and with CLL. It was not
possible in many cases to identify capping
and non-capping cells because of weak
SIg expression, which influences capping
reactions. In several cases pre-acetate-
wash cells exhibited strongly staining
polyclonal Ig on the cell surface. Two
patients (Tuc. (1) and Bas.) showed B
cells expressing Fc only: this profile was
encountered only in lymphomas of this
histological class and in CLL, where Fc
expression is always associated with IgM
expression. In 6 patients the B cells ex-
hibited SIg+Fc+C3+ profile, which is not
commonly found in other lymphomas.
The spleen biopsy specimen (Tuc. (3))
exhibited SIg+Fc+C3+IgM+ profile, pre-
viously described in CLL. Six patients had
SIg+ cells only; in 2 patients (Blo., Jac.)
SIg was expressed strongly, but only on
38% of cells in patient Jac. Three patients
exhibited the profile SIg+C3+, a lower
representation of this phenotype than in
DPDL or NPDL tumours. All patients
showed monoclonality of SIg after acetate
wash, and the intensity ofsurface staining
correlated with the Kiel histological classi-
fication. Of 8 biopsy specimens classified
as "malignant lymphoma, lymphoplasma-
cytoid" (ML Lpc) strong SIg staining was
seen in 7. Of the 11 biopsy specimens
classified as "malignant lymphoma,
lymphocytic" (MLL) only 1 (Smi.) showed
strongly staining SIg. In several cases
(those of Tuc. (2), Bes., Mar., New.) only
a minority of cells expressed SIg, the
major population being null. In no cases
were more than 10% ofcells found to have
CyIg.
Surface markers in non-classified turnours
(Table VIII)
Seven patients had lesions which did
not qualify them for inclusion in any of
the histological categories previously de-
scribed. Patient IqB had a mediastinal
tumour classified as "thymic blastoma",
composed of epithelial and lymphoid
elements of thymic derivation. The cells
present were T-derived and the lesion
classified at T-predominant, although the
epithelial component did not react in any
ofthe tests. Patient Hai. (1, 2) contributed
2 biopsy specimens ofa unique lymphoma,
thought to be a variant of centroblastic/
centrocytic tumour of diffuse type. The
patient Cor. had a plasmacytoma of
breast expressing CyIg of DL class. The
marrow and blood also contained neo-
plastic cells of this type. Patient Tat. had
marrow involvement with Waldenstr6m's
disease and, unusually, showed a poly-
clonal population of cytoplasmic IgM+
cells. In Patient Col. (2) the marrow ex-
amined 6 days after lymphnode biopsy
(Col. (1) DPDL) showed a T-cell-pre-
dominant Fc+, C3+ and IgM+ population.
The cytology (ML Hg Pleomorphic) was
quite unlike that ofthe lymphnode tumour
(CB/cc/D). Patient Umi., with histiocytic
medullary reticulosis, showed a receptor-
silent profile on node cells. Patient Pea.
presented with angio -immunoblastic
lymphadenopathy with dysproteinaemia.
The node profile suggested a T-cell neo-
plasm, but cytologically the predominant
cell type was immunoblastic. The disease
progressed to involve marrow and blood.
The immunoblastic cytology persisted
with E+ cell markers. This is the second
case of T-cell immunoblastic tumour in
this series (see patient Ham., DH).157 NON-HODGKIN LYMPHOMAS
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Variations inprofile and histology on repeat
biopsy
Changes in the histology of lymphomas
during the course ofthe disease frequently
involve conversion ofa nodular lymphoma
into diffuse lymphocytic or histiocytic
lymphoma. In an attempt to document
these changes, repeat biopsy specimens
were examined in 23 patients. In patients
Dep. (1, 2), Bro. (1, 2) and Tue. (2, 3)
lymphnode and spleen profiles were
assessed concurrently, where laparotomy
provided samples of involved spleen and
node on the same day. These are not in-
cluded in this section but are given in the
appropriate Tables. In 2 of these patients
the profile oftumour from node and spleen
was the same (Dep. (1, 2), Bro. (1, 2))
while in Tuc. (2, 3) the node profile
showed SIg+C3+ cells and the spleen
profile SIg+Fc+C3+IgM+ cells.
In the remaining 21 patients, the histo-
logical variation and the change in surface
profile, together with the interval between
biopsies is given in Table IX. Four types
ofchange occurred:
(1) Changes in histological appearance.
Nine patients (Mad., Smi., Has., Koz.,
Ted., Bri., Ayl., Cha., Cou.) showed
changes. In Mad., the change was from a
high-grade pleomorphic tumour into a
malignant lymphoblastic lymphoma. This
change was associated with loss of E+ by
the cells in this T-cell tumour, with rever-
sion to an E HTLA+ phenotype. In
patient Smi., the change from a malignant
lymphoma of centroblastic type into a
tumour containing both centroblasts and
immunoblasts was accompanied by a
change in profile from T predominance
with monoclonal B cells into a non-
capping lymphoma. In patient Has., the
histological pattern changed from CB/
cc/F (NPDL) to an immunoblastic malig-
nant lymphoma (DH) accompanied by a
change in phenotype from SIg+C3+ to a
non-capping B-cell tumour. In patient
Koz., 3 biopsy specimens showed marked
histological progression from a lympho-
plasmacytoid tumour to an unclassified
low-grade malignant lymphoma to an
immunoblastic lymphoma (DH). The pro-
file altered during this sequence from
SIg+C3+ to T-cell-predominant mono-
clonal B, and terminated in a non-capping
B cell tumour. Patient Ted. underwent 4
biopsies (1, 2, 3, 3a). Nodes 3 and 3a were
removed at one operation, 3 from the
inguinal region, 3a from the axilla. All
showed evidence of nodularity, but in
contrast to biopsy specimen 1, biopsy
specimens 2 and 3 showed some blast
transformation with evidence of pro-
gression to a diffuse tumour (from CB/cc/F
to CB/D). Biopsy specimen 3a showed
preservation of the follicular appearance
of biopsy specimen 1 (CB/cc/F). The
phenotype of the node cells showed
changes in the numbers of non-capping
cells, and in T cells associated with these
histological changes (Table VI). In patient
Bri., the histology altered from a nodular
and diffuse poorly differentiated tumour
to a diffuse mixed lymphocytic and histio-
cytic lymphoma accompanied by a change
in profile from SIg+C3+ to SIg+. In both
biopsy specimens SIg expression was
polyclonal. In patient Ayl., the histo-
logical change was from nodular mixed
lymphocytic and histiocytic lymphoma to
a nodular poorly differentiated tumour
with sclerosis. This was accompanied by a
change in profile from SIg+Fc+C3+ to
SIg+C3+. In patient Cha., an alteration
from a purely nodular tumour (NPDL;
CB/cc/F) to a mixed nodular and diffuse
tumour (N+DPDL, CB/cc/F+D) was not
accompanied by any change in profile. In
patient Cou., a nodular mixed lympho-
cytic and histiocytic tumour (CB/cc/F)
progressed to a nodular and diffuse poorly
differentiated lymphoma (CB/cc/F+D).
This was accompanied by a change in
profile from T-cell predominance to T-cell
predominance with monoclonal B cells.
(2) Changes in surface markers with no
histological change.-Patients Lov. (1, 2,
3), Eva. (1, 2), Gig. (1, 2, 3), Tue. (1, 2),
Wil. (1, 2), Hai. (1, 2) all showed changes
in lymphnode profile, unaccompanied by
changes in histology. In patient Lov., in
3 biopsies the histology showed diffuse157 NON-HODGKIN LYMPHOMAS
histiocytic lymphoma (ML CC/Lc in Kiel
classification). The profile changed from
T predominance with polyclonal B
cells to T predominance with no B
cells, eventually becoming receptor-silent.
The receptor-silent cells were not tested
with HTLA antisera. In patient Eva., the
profile changed from an SIg+C3+ tumour
into a T-predominant tumour with mono-
clonal B cells without any alteration in
histology. The SIg expressed by these cells
changed from YK to 11K. In patient Gig.,
in 3 biopsy specimens all showing nodular
poorly differentiated histology (CB/cc/F),
the profile changed from T-cell predomin-
ance with polyclonal B cells to Slg+C3+,
and in the last biopsy specimen to a "slow
capping" B-cell tumour. Alterations in
SIg expression also occurred in this
tumour. In patient Tuc., with diffuse well
differentiated lymphoma ofCLL type, the
initial lymphnode biopsy specimen showed
SIg+Fc+ B cells, while the second lymph-
node biopsy showed SIg+C3+ B cells. In
the first 2 biopsy specimens of patient
Wil. (1, 2), both classified as NPDL, a
change in profile from an SIg+C3+ tumour
to an SIg+ tumour occurred. In Hai., with
a variant of centroblastic centrocytic
lymphoma, the initial profile was of T-cell
predominance with polyclonal B cells. The
second biopsy specimen, of similar histo-
logical appearance, gave an SIg+ B-cell
profile.
(3) Changes in expression of SIg.-
Patients Smi., Koz. (1, 2, 3), Ted., Eva.,
Cou., Gig. (1, 2, 3),Tuc. (1, 2),Wil. (2, 3)and
Hai. all showed changes in SIg expression
in the repeat biopsies. Patient Smi.
showed a change from PA to YPK with the
appearance ofy chain as well as , on most
cells in the second biopsy specimen.
Patient Koz. showed an odd variation
from /K monoclonality to expression of K
only, followed by a reappearance of PK in
the third biopsy specimen. In Patient
Ted., the initial biopsy specimen was ILA
monoclonal, the last (3a) showed pA SIg
with some yA CyIg+ cells. In Eva., the
heavy-chain class altered from y to ,u in a K
chain-expressing tumour between the first
and second biopsies. In Cou., no SIg+ cells
occurred in the first biopsy specimen, but
>10% of cells in the second biopsy speci-
men were B cells and were FK monoclonal.
In patient Gig., a B-cell component be-
came predominant between the first and
second biopsies and there was a change
from polyclonal SIg expression to y,A
expression. Between the second and third
biopsies, IL expression was lost, giving a
yA monoclonal B-cell tumour. In Patient
Tuc., the first biopsy specimen showed
only H heavy chain on the B cells; the
second biopsy showed VK monoclonality.
In Patient Wil. (2, 3) a yK monoclonal SIg
profile in the second biopsy specimen had
become polyclonal by the time ofthe third
biopsy. In Patient Hai., a polyclonal B-
cell component seen at the first biopsy
expanded to a monoclonal B-cell com-
ponent by the second biopsy, expressing
PK Slg.
(4) No change in histology or profile.-
Patients Bre., Bret., Pet., Sul., did not
show changes either in histology or profile
between the first and second biopsies. If
allowance is made for the fact that the
second biopsy in Bre. was done on cells
from a malignant effusion, the profiles
obtained (Table III) are probably equiva-
lent, although in the node biopsy IgM
receptor was present on a substantial pro-
portion of T cells, and C3 was less well
represented than in the pleural effusion.
It is of interest that the SJg expression in
both Bret. and Sul. remained polyclonal
in both biopsy specimens, and no altera-
tion in histology or profile was seen.
In Patients Pea. and Cal., changes in
histology and profile are not comparable
with those described in the other patients.
In Patient Pea. the original biopsy speci-
menwasnot diagnosed aslymphoma. Only
later, with the appearance of many circu-
lating immunoblasts, was the progressive
nature of the tumour appreciated. Pro-
files on blood, in our experience, are rarely
interpretable in the same way as node or
spleen profiles, and are probably the least
representative of the involved tissues in
non-Hodgkin lymphoma. In Patient Col.,
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Table X.-Percentage Ig expression in B lymphomas ofd(fferent histological class
Ig class expressed
Class
DU
DHL
DPDL
NPDL
DWDL
100
57
75
54
53
y
40
50
38
17
16
oc
0
0
4
0
0
K
80
64
38
37
74
A
20
21
50
31
16
20
21
21
3
I.LK 5
Poly-
clonal
0
7
8
29
0
K/A
ratio
400
3-00
0-76
1-20
4-60
H or L
chain only
0
6
7
7
47
it is possible that 2 separate proliferating
populations were initially present: B cells
in lymphnode and T cells in marrow.
Expression of SIg class in non-Hodgkin
lymphomas of different histological type
(Table X)
The majority of neoplasms express ,u
heavy chain as the major immunoglobulin
heavy-chain class. y Heavy chain is ex-
pressed with similar frequency in DU,
DH, and DPDL lymphomas, but is rarely
expressed inNPDL or DWDL lymphomas.
Single-chain expression is unusual in DU,
DH, DPDL or NPDL, but is very common
in DWDL. In DHL, DU and DWDL, K
light chain is expressed more frequently
than A; in DPDL A chain is expressed
more frequently than K. In NPDL the K/A
ratio is of the same order as in normal
lymphnode cell suspensions. The number
of B-cell-predominant polyclonal SIg+
tumours is greater in NPDL lymphoma
than in the other classes.
DISCUSSION
1. Relationship of surface marking to
histology
Of the many available classifications of
non-Hodgkin lymphoma we chose to base
this paper on two, the Rappaport scheme
because ofits proven clinical applicability,
and the Kiel because it is one of the two
major classifications embodying the Lukes
and Collins follicular-centre-cell concept
(Lukes & Collins, 1975; Gerard-Marchant
et al., 1974). Both classifications have
strong and weak points: the Rappaport is
simple to understand, and easy to apply.
The major defect in the scheme lies in the
mistaken concept of lymphocyte "differ-
entiation" and in the division between
histiocytic lymphomas (which are mainly
lymphocytic) andlymphocytic lymphomas
(Habeshaw et al., 1977). The Kiel classi-
fication avoids these drawbacks, but is of
a higher order of complexity and is largely
unproven "in the field" of clinical applic-
ability. In the first part of this discussion
an attempt will be made to assess the
validity of certain Kiel concepts, namely
the ability to distinguish between B- and
T-cell lineages cytologically, to identify
follicular-centre-cell lesions, and to ex-
plore the Kiel division of the Rappaport
"DWDL" lymphoma, into lymphocytic
and lymphoplasmacytoid subgroups.
In the Kiel classification, lymphoblasts
of B and T type are distinguished from
those of ALL+ type by cytology (con-
voluted nucleus, acid-phosphatase-posi-
tive T, cytoplasmic vacuolation and
basophilia B). As shown in Table III, in 7
cases of T-lymphoblastic lymphoma
proven by phenotype, 5 showed the cyto-
logical features of T lymphoblasts.
Patients Leg. and Mad. did not show
these features, and in both cases the
lymphoblasts were E- and HTLA+. These
two cases may represent tumours of pre-
thymic T lymphocytes (Kersey et al.,
1974). Of the 5 B-lymphoblastic lymph-
omas, 3 showed Burkitt-lymphoma-like
features. Of interest is the presence of
cytoplasmic immunoglobulin in 2 of these
tumours, suggesting a relationship with
the pre-B cell (SIg-CyIgM+ phenotype).
The Kiel classification stresses the inter-
relationship between centrocytes of large-
and small-cell type, centroblasts, and
immunoblasts as successive stages in the
maturation of follicular lymphocytes to157 NON-HODGKIN LYMPHOMAS
plasma cells. Lukes proposes a similar but
not identical maturation sequence ofsmall
cleaved cell, large cleaved cell, small non-
cleaved cell and large non-cleaved cell to
the B-cell immunoblast. In terms of
surface phenotype, normal follicular
tissues show the presence of centrocytes
ofsmall- and large-cell type, which exhibit
the SIg+C3d+ phenotype. Associated with
these B cells are normally found a signifi-
cant proportion of small and transformed
cells (not centrocytes) which express E-
rosetting capabilities, and are HTLA+. In
the tumours examined, most tumours
containing SIg+C3d+ B cells had centro-
blastic and centrocytic morphology. How-
ever, of the 52 cases of centroblastic and
centrocytic type, only 24 showed SIg+C3d+
phenotype. In 26 ofthese 52 cases, centro-
blastic and centrocytic tumours contained
more than 20% of T lymphocytes, and
some were T-lymphocyte-predominant.
While there remains a good correlation
between monoclonal B-cell-predominant
tumours and the histological class "centro-
blastic and centrocytic" lymphoma, it is
apparent that the B-cell subtype SIg+C3d+
is not detected in these tumours by
morphology and cytology. The centro-
blastic component ofthe centroblastic and
centrocytic tumour may well be T- rather
than B-derived on the evidence of this
series, because (1) 60% of purely centro-
blastic tumours were T-cell predominant;
(2) centrocytic tumours of small- and
large-cell type were B lymphoid; and (3)
of the high incidence with a T-cell popu-
lation >20% in tumours with a centro-
blastic component. If the "centroblast"
is T-lymphoid, the relationship between
the 2 centrocytic components and the
immunoblast becomes easier to under-
stand. The small-cell centrocytic tumours
are frequently SIg+C3d+; some fail to cap
SIg. The large-cell centrocytic tumours
appear to lack C3d receptors, and are
phenotypically similar to the B immuno-
blast (non-capping SIg+). Small - cell
centrocytic tumours and some centro-
blastic and centrocytic tumours have the
phenotype SIg+, which is also common in
lymphoplasmacytoid malignancies. The
latter can express SIg+C3d+, and SIg+Fc+
C3d+ phenotypes in addition. Our inter-
pretation of the interrelationships of
follicular lymphocyte subtypes in the Kiel
classification would favour: (1) centro-
blast, and the non-transformed "small
non-cleaved cell" of Lukes are T cells and
represent the T-cell component associated
with follicular B cells; (2) the small
centrocyte (SIg+C3d+) transforming to
the large centrocyte (SIg+, non-capping)
and to the immunoblast (non-capping
SIg+) or remaining untransformed, giving
risetothe "lymphoplasmacytoid" lympho-
cyte (SIg+, SIg+Fc+C3d+). Immunoblasts
of T type would, in this scheme, be de-
rived from the centroblastic component
of a centroblastic and centrocytic malig-
nancy. Another prominent distinction
between the Kiel and Rappaport classi-
fications is the category oflymphoplasma-
cytoid malignancy in the Kiel classifica-
tion, which forms a part of what Rappa-
port would call DWDL. On phenotypic
grounds tumours of lymphoplasmacytoid
type are quite clearly different from
tumours of lymphocytic type. Lympho-
plasmacytoid tumours exhibit capping
SIg strongly, while the lymphocytic
tumours show weak SIg expression, rather
like the peripheral-blood lymphocyte in
CLL. Although lymphoplasmacytoid
tumours rarely contain more than 10% of
Cylg+ cells, some are always present,
whilst in lymphocytic tumours plasma
cells are very rare. From Table VII the
correlation between strong SIg expression
and lymphoplasmacytoid histology, and
between weak SIg expression and lympho-
cytic histology is clearly shown.
In respect of the recognition of the
classes of follicular-centre-cell derived
tumours, the categorization morphologic-
ally and cytologically of T- and B-
lymphoblastic tumours, and the distinc-
tion between the lymphoplasmacytoid
and lymphocytic forms of diffuse lymph-
oma, the Kiel classification offers distinct
advantages over the Rappaport scheme.
The current limitations of histological and
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cytological classification using either Kiel
or Rappaport are also apparent when the
phenotypic correlations are taken into
account. Neither scheme recognizes sub-
types of B cell clearly defined by pheno-
type. Neither scheme achieves a one-for-
one correlation of phenotype and morph-
ology, even in a cytologically distinctive,
monomorphic population. The conclusion
clearly is that subsequent classifications
of non-Hodgkin lymphoma must include
surface marking as one of the diagnostic
criteria.
When the correlations between surface
marking and histology in the series of
repeat biopsy specimens is examined,
relationships between surface markers and
histology become difficult to interpret.
There is clear evidence of a relationship
between T-cell-predominant monoclonal
B-cell tumours, tumours of S1g+C3+ class
and non-capping B-cell tumours of im-
munoblastic type. These sequences sup-
port the contention that tumours of
follicular derivation are related to im-
munoblastic tumours. In terms of surface
markers, there is strong evidence for
believing that T-predominant monoclonal
B-cell tumours and S1g+C3+ tumours are
also functionally related, the end stage
being either an SIg+ non-capping or an
SIg+ tumour. The occurrence of T-cell
predominance as one phase in the develop-
ment of an SIg+C3+ or non-capping SIg+
tumour has not previously been recog-
nized. It is of importance, since in the
normal immune response T cells accumu-
late in lymph nodes early, and their
accumulation and division precede B-cell
hyperplasia and antibody secretion
(Davies etal., 1969). Centroblastic tumours
(although rare in this series) seem to
correlate with the T-cell-predominant
phase of what later becomes a B-cell-
predominant tumour. Although the evi-
dence is limited, we would like to suggest
that the tumour of SIg+C3d+ phenotype
is sandwiched between 2 T-cell-predomi-
nant phases, one of which precedes the
expansion of the SIg+C3d+ clone, and the
other which marks the transition between
the SIg+C3d+ phenotype and the capping
or non-capping SIg+ tumour. During the
first phase, the emergence of a follicular-
cell pattern occurs, and during the second
a change from a nodular to diffuse histo-
logical pattern is seen. Immunoglobulin
switching from ,u to y class, and the
synthesis of CyIg probably occur after the
second phase of T-cell predominance.
2. Deductions about the nature of NHL
from these studies
Lymphomas are tumours ofthe immune
system. The fact that they arise at all
reflects some profound disturbance not
just in the cell class termed "neoplastic"
but in the precursors of that cell and in
related cells which physiologically regulate
the normal response to an antigen. A stem-
cell defect in this system may be latent in
both B- and T-cell lines, without com-
promising the function ofeither, until they
meet the appropriate antigenic stimulus.
If the defect is expressed in immunologic-
ally competent cells, and concerns events
which occur after exposure of the cell to
antigen, it will only become apparent as a
failure of that cell to complete the im-
mune response which would normally
follow such exposure. In this sense, non-
Hodgkin lymphoma (NHL) can be re-
garded as an abnormal immune response
equivalent to a selective immune defici-
ency, limited to one clone of cells and
evoked by a single antigen. Evidence for
this statement is based on the close
similarity between the chromosomal de-
fect in ataxia telangiectasia and defects
described in various forms of lymphoma
(Louie & Schwartz, 1978; McCaw et al.,
1975; Fukahara et al., 1976; Manolov &
Manolova, 1972) and on the antibody
activity of monoclonal immunoglobulins
isolated from patients with lymphoma
(Salmon & Seligmann, 1974).
Lymphomas can be broadly divided into
two groups: (1) occurring before full
functional differentiation of the lymphoid
cells has been achieved and (2) tumours of
differentiated lymphocytes. In Group 1
the tumours are of immunologically157 NON-HODGKIN LYMPHOMAS
incompetent cells, and are independent of
any antigenic stimulation. In Group 2 the
tumours are of immunologically compe-
tent cells which are maturation-arrested
at some stage in their response to an anti-
gen. The defect (or oncogenic event) may
be present in either tumour from the stem-
cell stage, but in Group 1 tumours is ex-
pressed before the cell has achieved
immunocompetence and in Group 2
tumours after functional differentiation is
complete. Using this model it is possible
to utilize the available evidence of normal
differentiation to explore the nature of
NHL.
Tumours of incompetent cells are the
ALL+Ia+ lymphoblastic and the T-cell
lymphoblastic lymphomas, including the
E+C3+ subset. These tumours are usually
TdT+ (Kung et al., 1978). It is during this
phase of development that B and T cells
acquire their antigen receptors by a pro-
cess of proliferation, somatic mutation
and elimination of self-antigen-reactive
clones (Jerne, 1971). It has been suggested
that TdT enzyme is important during the
somatic mutation step in which the
variable-region genes are assembled which
code for the antigen-receptor sites on both
the T-cell surface and the immunoglobulin
molecule (Baltimore, 1974). The tumours
of immunologically incompetent B cells
are represented only by the pre-B cell
ALL, since a measure of immunocompe-
tence is present from the exhibition of
SIg. All SIg+ B-cell tumours are TdT-
(Kung et al., 1978; Donlon et al., 1977;
Habeshaw et al., submitted for publica-
tion). Immature, but SIg+ B cells have
some immunocompetence. Their matura-
tion can be blocked at this stage by anti-
IgM antibody (Kearney et al., 1976). After
contact with anti-IgM, immature B cells
shed their SIg and fail to secrete it again
until the blocking agent is removed
(Stocker, 1977; Sidman & Unanue, 1975).
The effects of "blocking" B cells are
reminiscent of the effects of removing
polyclonal antibody from CLL cells by
acetate washing, where only a weak or
residual SIg positivity is retained, or in
3
some cases no SIg expression at all. For
this reason, the weakly staining CLL cells,
and the malignant lymphomas oflympho-
cytic type may be tumours of immature
B cells. It has been shown that Fe ex-
pression is an early characteristic of the
B cell, preceding acquisition of the C3
receptor (Abbott et al., 1976), and that
SIg+Fc+ B cells require the presence of
primed T cells and macrophages in order
to respond to an antigen (Hoffman et al.,
1976). Virgin B cells, with SIg+Fc+C3+
(and possibly IgM+) phenotype, can re-
spond to antigen in the presence of un-
primed T cells and macrophages (Kearney
et al., 1978). The presence of weak SIg
expression and SIg+Fc+(IgM+) phenotype
as in CLL, might suggest tumours of
immunocompetent but immature B cells.
The profile of the virgin B cell is perhaps
SIg+Fc+C3+IgM+, with surface IgM or
IgM+D as the major SIg class (Coffman &
Cohn, 1977). Most NHL are composed of
B cells derived from the later phases of
B-cell maturation. During germinal-
centre development expansion and selec-
tion of antigen-reactive clones derived
from marrow precursors occurs (Niewen-
huis et al., 1974; Niewenhuis & Keuning,
1974). The products of such selection are
plasma-cell precursors and memory cells
which, though derived from the same
clone, probably belong to different matura-
tion compartments (Zauderer & Askonas,
1976). Tumours of germinal-centre cells
are represented by those of SIg+C3+
profile. Memory-cell tumours are of un-
known profile, but since normal memory
cells circulate and accumulate in the
spleen (Niewenhuis & Keuning, 1974)
their tumours may have SIg+Fc+C3+
phenotype. According to one view (Ham-
merling et al., 1976) the SIg+C3+ precursor
from marrow has SIg+C3- phenotype.
T-cell help may be required for the
differentiation of the SIg+C3+ B cell into
a plasma-cell precursor (Lewis et al., 1976).
Pro-plasma cells do not recirculate and
they probably express SIg+ or SIg+CyIg+
profiles.
It is possible to identify those critical
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points in normal lymphocyte development
at which tumours arise. These are (1) at
stem-cell stage (ALL+la+TdT+) or early
in the differentiation sequence (pre-B,
pre-thymic and thymic T cell); (2)
between acquisition of SIg and virgin
B-cell stage (as in MLL and CLL); (3)
during germinal-centre formation (SJg+
C3+ tumours) in which there is at least one
T-cell-predominant phase; or (4) during
the change from SIg+ to Cylg+ cell,
which may also include a T-cell-pre-
dominant phase and be accompanied by
IgM-G switching and blast-cell trans-
formation. The question how these
maturation arrests occur should provide
a useful challenge to the continuing in-
vestigation of non-Hodgkin lymphoma.
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